Press Release: Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD

CANNANNEW REPORT

TORONTO, Feb. 4, 2021 /PRNewswire/ – Diamond Therapeutics Inc. (“Diamond“), a leading psychedelic drug development company focused on low-dose therapies… Read More….. The post Press Release: Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Press Release: Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.